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Abstract 29 
Purpose: We determined the effect of supressing lipolysis via administration of Nicotinic acid (NA) and pre-30 
exercise feeding on rates of whole-body substrate utilisation and cycling time-trial performance (TT). Methods: 31 
In a randomised, single-blind, crossover design, 8 trained male cyclists/triathletes completed two series of TT’s 32 
in which they performed a predetermined amount of work calculated to last ~60, 90 and 120 min. TT’s were 33 
undertaken after a standardised breakfast (2 g·kg−1 BM of carbohydrate [CHO]) and ingestion of capsules 34 
containing either NA or Placebo (PL). Results: Plasma [free fatty acids] were supressed with NA but increased 35 
in the later stages ofTT90 and TT120 with PL (p<0.05). There was no treatment effect on time to complete 36 
TT60 (60.4 ±4.1 vs. 59.3 ±3.4 min) or TT90 (90.4 ±9.1 vs. 89.5 ±6.6 min) for NA and PL, respectively. 37 
However, TT120 was slower with NA (123.1 ±5.7 vs. 120.1 ±8.7 min, p<0.001), which coincided with a decline 38 
in plasma [glucose] during the later stages of this ride (p<0.05). For TT’s of the same duration, rates of whole-39 
body CHO oxidation were unaffected by NA, but decreased with increasing TT time (p<0.05). CHO was the 40 
predominant substrate for all TT’s contributing between 83-96% to total energy expenditure, although there was 41 
a small use of lipid-based fuels for all rides. Conclusion: 1) NA impaired cycling TT performance lasting 120 42 
min, 2) cycling TT’s lasting from 60 to 120 min are CHO dependent, and 3) there is an obligatory use of lipid-43 
based fuels in TT’s lasting 1-2 h. 44 
 45 
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Abbreviations: 48 
BM – body mass 49 
CHO – carbohydrate 50 
FA – fatty acid 51 
FFA – free fatty acids 52 
HR – heart rate 53 
IMTG – intramuscular triglyceride 54 
LMM – linear mixed model 55 
NA – nicotinic acid 56 
PL – placebo 57 
PPO – peak power output 58 
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RER – respiratory exchange ratio 59 
RPE – rating of perceived exertion 60 
TG – triglycerides 61 
TT – time trial 62 
V̇O2max – maximal oxygen consumption 63 
W – Watts   64 
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Introduction 65 
The question of what fuels support muscle contraction during exercise has been a topic of long-66 
standing interest to physiologists since the early 1900’s (for a review see Hawley et al. 2015), and today it is 67 
well accepted that during continuous activities lasting more than a few minutes duration, both intra- and extra-68 
muscular carbohydrate and lipid substrates are the predominant substrates oxidised by the working muscles. 69 
Furthermore, there is consensus that at the intensities at which competitive endurance athletes train and race (i.e. 70 
>65% of V̇O2max), the primary determinant of the balance of carbohydrate (muscle and liver glycogen, blood 71 
glucose and lactate) and lipid (adipose and intramuscular triglycerides, blood-borne free fatty acids [FFAs] and 72 
triglycerides) fuels for the working muscles is the relative exercise intensity (Bergman et al. 1999; Romijn et al. 73 
1993; van Loon et al. 2001). However, the energy available from endogenous carbohydrate stores are limited, 74 
while fat stores, even in highly trained individuals, are abundant (Martin and Klein 1998). Consequently, 75 
increasing the contribution from fat-based fuels to the total energy requirements of prolonged, intense endurance 76 
exercise could ‘spare’ endogenous carbohydrate reserves and improve endurance capacity. Several studies have 77 
used a combination of dietary and other interventions to increase fat availability before and during exercise 78 
(Burke et al. 2000; Burke and Hawley 2002; Carey et al. 2001) and while such strategies result in robust 79 
increases in fat oxidation and reduce muscle and liver glycogen utilisation, they fail to improve performance in 80 
endurance tasks lasting several hours (Burke et al. 2000; Carey et al. 2001; Havemann et al. 2006). 81 
In contrast to increasing fat availability before or during endurance exercise, several studies have 82 
determined the effect of reducing fatty acid (FA) availability on substrate metabolism and performance. This has 83 
typically been achieved by administration of drugs that block lipolysis such as Nicotinic acid (NA) (Bergström 84 
et al. 1969; Murray et al. 1995) or Acipimox (Zderic et al. 2004). Murray, et al. (1995) reported that inhibiting 85 
the exercise-induced rise in FFA concentration (via NA administration) had no effect on a cycling time-trial 86 
(TT) lasting ~15 min, while Hawley, et al. (2000) showed little effect of either increasing (via a high-fat meal 87 
and intravenous heparin administration) or decreasing (via NA ingestion) fat availability on ~30 min cycling TT 88 
performance. These studies (Hawley et al. 2000; Murray et al. 1995) both used intense cycling protocols lasting 89 
<30 min during which CHO-based fuels would be expected to be the major energy source for oxidation by the 90 
working muscles (Romijn et al. 1993), independent of fat availability. However, as exercise duration increases, 91 
reliance on CHO-based fuels declines while that from fat-based fuels increase (Brooks and Mercier 1994; 92 
Romijn et al. 1993). Consequently, if FA availability and oxidation is obligatory during maximal exercise 93 
lasting >60 min, blocking lipolysis may impact negatively on performance. Hence the aim of the present study 94 
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was to determine the effect of inhibiting the endurance exercise-induced rise in plasma FFA levels before and 95 
during simulated cycling TTs lasting ~60, 90 and 120 min. We hypothesised that reducing FA availability 96 
would not impair performance of TTs of these durations and that CHO-based fuels would be the major source of 97 
fuel for oxidative metabolism. 98 
 99 
Methods 100 
Subjects 101 
Eight trained male cyclists/triathletes aged 18-40 y, with a V̇O2max >60 mL·kg·min-1 and ≥2 y TT racing 102 
experience, were recruited to participate in this study. At the time of investigation, all subjects were cycling a 103 
minimum of 200 km·wk-1. Subjects were informed of the nature of the study and possible risks involved before 104 
giving their written consent. The study was approved by the Human Research Ethics Committee of the 105 
Australian Catholic University (Reference number 2014 51V). The study was prospectively registered with the 106 
Australian New Zealand Clinical Trials Registry (ACTRN12614000629639).  107 
Preliminary testing 108 
Two weeks prior to commencing their first experimental trial, subjects performed a maximal, 109 
incremental cycle test to voluntary exhaustion on an electromagnetically-braked ergometer (Lode Excalibur 110 
Sport, Groningen, The Netherlands) to determine V̇O2max and peak sustained power output (PPO, the peak 111 
work-load attained at the completion of the test [W]), as described previously (Hawley and Noakes 1992). 112 
Briefly, the test protocol commenced at 3.33 W∙kg-1 for 150 s and thereafter was increased by 50 W for a further 113 
150 s. Subsequently, increases of 25 W every 150 seconds occurred until volitional fatigue or a drop in cadence 114 
below 70 rev·min-1. During the maximal test and portions of the experimental trials expired breath was 115 
measured for oxygen and carbon dioxide expired using a calibrated online gas analyser (True One 2400 Parvo 116 
Medics Metabolic Measurement System). V̇O2max was determined as the highest 30s average V̇O2 117 
consumption. All testing sessions were conducted under standard laboratory conditions (18-22 °C, 40-50% 118 
relative humidity), and subjects were fan cooled during all exercise sessions. 119 
Exercise and dietary control 120 
In the 48 h prior to each experimental trial subjects abstained from any vigorous physical activity. Any 121 
exercise completed during this time was of low intensity (<60% of V̇O2max) and short duration (≤1 h) and 122 
recorded by the subject each week in a training log. The same training was then repeated before subsequent 123 
trials. Subjects were provided with a pre-packaged standardised diet containing 8 g CHO·kg−1 BM for the 24 h 124 
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before each trial and requested to abstain from caffeine-containing beverages (i.e., tea, coffee, cola, energy 125 
drinks) and alcohol consumption during this period. On each trial day, subjects consumed a standardised 126 
breakfast of 2 g CHO·kg−1 BM 2 h before the start of a TT. Dietary records and training logs were kept to 127 
ensure compliance.  128 
Familiarisation session 129 
All subjects completed a familiarisation session one week prior to the start of their first experimental 130 
trial to habituate to laboratory conditions and the experimental protocol. Using the same protocol as 131 
experimental trials (described subsequently) subjects completed a ~30 min TT. All familiarisation sessions and 132 
experimental trials were undertaken on the same ergometer. Blood samples were not taken during the 133 
familiarisation session and NA was not administered.  134 
Overview of the experimental design 135 
An overview of the experimental protocol is shown in Figure 1. In brief, in a randomised, single-blind, 136 
crossover design, eight trained male cyclists/triathletes undertook two series of three simulated TTs during 137 
which they completed specific amounts of mechanical work calculated to take ~60, 90 and 120 min. In one 138 
series of rides subjects were administered NA, while the second series acted as a placebo control. In total, 139 
participants completed six TT’s over an 8 wk period. On the day of a trial, subjects arrived at the laboratory at 140 
~0700 h after a 10 h overnight fast. After voiding, a Teflon catheter (20-22G; Terumo, Japan) was inserted into 141 
the antecubital vein of one arm to allow for serial blood sampling. After a resting blood sample (6 mL) was 142 
taken, subjects ingested the standardised breakfast and rested for 105 min. At this time subjects were weighed 143 
and commenced a warm up (15 min at 60% of individual PPO (~70% V̇O2max)) followed by 1 min rest. 144 
Subjects were then informed of the length of the TT to be completed that day and were given a brief count down 145 
to the start of each ride. Subjects were encouraged to complete the designated work as fast as possible and 146 
provided with financial incentives for the fastest total time to complete all six TTs (for first, second and third 147 
place, respectively). Water was ingested ad libitum during the TT and total fluid intake was recorded. BM was 148 
measured upon completion of each TT. Expired air was measured at 20 min intervals during the TTs at the same 149 
time as ratings of perceived exertion (RPE) using the Borg Scale (Borg 1982) and heart rate (HR) using 150 
telemetry (Polar, Kempele, Finland). 151 
Blood sampling 152 
Blood samples (6 mL) were taken upon arrival at the lab, 20 min after the commencement of the 153 
ingestion of breakfast, at the start of the warm up, at the start of each TT and at the completion of each third of 154 
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the total workload to be completed in that TT (Figure 1). Following each blood sample, and at regular 20-30 155 
min intervals, catheters were flushed with 3-5 mL saline (0.9% NaCl g·L-1). Blood samples were collected in 6 156 
mL EDTA tubes and spun at 3500 RPM for 10 min at 4 ºC. The resultant plasma was aliquoted and stored at -80 157 
ºC for later analyses.  158 
Respiratory gases measurement 159 
During the familiarisation session and experimental trials, expired air was measured for three 160 
consecutive min at the 5 min time-point of the warm up, at the 5 min time-point of the TT and at regular 20 min 161 
intervals during each TT to estimate rates of substrate oxidation from the non-protein respiratory exchange ratio 162 
(RER =V̇CO2/V̇O2). The final expired gas collection for each TT was taken during the last 100 kJ of work. For 163 
each time-point, the first 30 s of data was removed and therefore the final 150 s of data was averaged. Mean 164 
RER values were calculated across all measurement time-points within a TT. 165 
Nicotinic acid/placebo administration 166 
NA or placebo treatments were administered in capsule form. NA was given 30 min (10 mg·kg−1BM) 167 
and 15 min (5 mg·kg−1BM) prior to the start of a designated trial, with a further 5 mg·kg−1BM ingested every 30 168 
min during TTs. Placebo capsules were indistinguishable from NA capsules in taste and colour, and were 169 
provided to subjects at the same time-points. Dosages were prescribed based on previous NA studies and taking 170 
into consideration exercise intensity and duration (Gollnick et al. 1981; Grundy et al. 1981; Murray et al. 1995; 171 
Hawley et al. 2000). 172 
Time trial protocol 173 
Simulated cycling TTs were undertaken with the ergometer set in a cadence-dependent power-output 174 
(linear) mode for subjects to complete set amounts of mechanical work for different TT durations. Power output 175 
was therefore function of cadence and a fixed factor (alpha value) as described in the following equation: Power 176 
(W) = [Cadence (rpm)]2 x [alpha (W/rpm2)].  A custom-determined, alpha value was assigned to each individual 177 
for each trial duration based on the calculations of total workload and expected cadence as described below. The 178 
amount of work to be completed during each TT duration was calculated according to each subject’s PPO and 179 
based on previous data (Jeukendrup et al. 1996) and pilot testing. We estimated that subjects would be able to 180 
maintain average power-outputs equivalent to ~75, 74, and 73% of individual PPO for the 60, 90 and 120 min 181 
TTs, respectively. Accordingly, the mechanical power-output to be completed was determined as follows: 182 
~TT60 min TT Work (joules) = 0.75 x PPO x 3600 s 183 
~TT90 min TT Work (joules) = 0.74 x PPO x 5400 s 184 
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~TT120 min TT Work (joules) = 0.73 x PPO x 7200 s 185 
 186 
Alpha values for the linear mode were calculated for subjects to cycle at a cadence of 100, 97 and 95 187 
rev·min-1 for the 60, 90 and 120 min TTs respectively to complete the trial in the estimated time. Cadence for 188 
each duration was based on previous validation of the 60 min TT protocol (Jeukendrup et al. 1996), accounting 189 
the effect of exercise duration on cadence selection (Hansen and Smith 2009), and corroborated during pilot 190 
testing. To simulate race conditions and allow optimal pacing strategy, subjects were provided with real-time 191 
feedback pertaining to power output, HR, cadence, elapsed time and total mechanical work. 192 
Analytical techniques 193 
Plasma FFA concentrations  were measured using a non-esterified-fatty acid (NEFA) assay kit (Wako 194 
Pure Chemical Industries, Ltd, Osaka, Japan). Plasma glucose and lactate concentrations were analysed using a 195 
YSI 2300 STAT Plus™ analyser (Yellow Springs, USA). Whole-body rates of CHO and fat oxidation (g·min-1) 196 
were determined for each steady-state gas measurement point from the rates of CO2 production (V̇CO2) and O2 197 
consumption (V̇O2) using the non-protein RER values (Péronnet and Massicotte 1991). These equations are 198 
based on the assumption that V̇O2 and V̇CO2 accurately reflect tissue O2 consumption and CO2 production. In 199 
well-trained subjects, similar to those employed in the current investigation, indirect calorimetry has been 200 
shown as a valid method for quantifying rates of substrate oxidation during strenuous exercise at 85% V̇O2max 201 
(Romijn et al. 1992).  202 
 203 
Statistical analysis 204 
Statistical analysis was undertaken using two way (duration × treatment) repeated measures ANOVAs 205 
(IBM SPSS Statistics, version 22). Where ANOVA revealed significant differences of time, post-hoc analyses 206 
(Student–Newman–Keuls) were conducted. Linear mixed models (LMM) were used to analyse data which had 207 
more than one time point (i.e. blood glucose, lactate, FFA, and power output). Subsequent post-hoc comparisons 208 
(Bonferroni) between the two treatment groups were conducted within the LMM.  Statistical significance was 209 
set at p<0.05. All data are presented as mean ±SD, with 95% confidence intervals (CI) where appropriate. 210 
 211 
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Results 212 
Subjects 213 
One subject was unable to complete the workload for NA TT120 and therefore his data was excluded 214 
from all trials. Consequently, seven subjects were included in the final analysis (age 26 ±6 y, body mass (BM) 215 
76.1 ±13.1 kg, peak power output (PPO) 409 ±57 W, maximal oxygen consumption (V̇O2max) 4.9 ±0.7 216 
L·min−1). 217 
Blood parameters 218 
Plasma free fatty acid concentrations 219 
Plasma FFA concentrations were similar before all TTs (Figure 2). There were main effects for both 220 
treatment (p<0.003), trial duration (p=0.044) and time (p<0.001), as well as an interaction effect of treatment × 221 
duration × time (p<0.001), on plasma FFA concentrations. There was a significant increase in plasma FFA 222 
concentrations at the end of the PL TT90 and PL TT120 compared to the respective NA trials (TT90: p<0.001, 223 
95%CI: 113 – 257 mEq/L; TT120: p<0.001, 95%CI: 149 – 303 mEq/L). During TT90 and TT120, FFA 224 
concentrations were higher for PL compared to NA after two-thirds of the total work to be completed (TT90: 225 
p<0.01, 95%CI: 23 – 167 mEq/L; TT120: p<0.002, 95%CI: 43 – 197 mEq/L) and at completion (TT90: 226 
p<0.001, 95%CI: 113 – 257 mEq/L; TT120: p<0.001, 95%CI: 149 – 303 mEq/L).  227 
Plasma glucose concentrations 228 
There was a main effect of time (p<0.001) and trial duration (p<0.001) for plasma glucose 229 
concentration (Figure 3), with no treatment or interaction effects. Plasma glucose concentration increased above 230 
rest following the ingestion of breakfast (-100 min) in all trials (p<0.04) after which there was a decrease below 231 
resting values until exercise was commenced (p<0.001). After one-third of the total work was completed for the 232 
respective TTs plasma glucose levels had returned to baseline values. In contrast, at the end of the NA TT120, 233 
there was a drop in plasma glucose concentration compared to baseline (p=0.048, 95%CI: -2.02 – -0.004 mM) 234 
and the one-third of the total work time point (p=0.007; 95%CI: -2.20 – -0.18 mM). Compared to PL, NA also 235 
reduced plasma glucose concentration at the end of TT90 (p=0.03; 95%CI: -1.27 – -0.06 mM) and TT120 236 
(p=0.03; 95%CI: -1.32 – -0.07 mM).  237 
Plasma lactate concentrations 238 
There were main effects of duration (p<0.001) and time (p<0.001), but no treatment or interaction 239 
effect, on plasma lactate concentrations (Figure 4). At the onset of exercise, plasma lactate concentration 240 
increased above rest at the onset of exercise and remained elevated throughout exercise (p<0.05) for all trials. 241 
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With the exception of NA TT120, plasma lactate concentrations were elevated at the end of all TTs (p<0.001) 242 
compared to values measured after completion of one-third of the total work. Plasma lactate concentration in 243 
NA TT120 was reduced (p<0.001; 95%CI: -4.0 – -1.5 mM) at the end of the experimental ride compared to PL. 244 
Respiratory parameters and rates of substrate oxidation 245 
Table 1 and 2 display the respiratory and metabolic data, respectively, for all experimental trials. There 246 
was a main effect of TT duration (p<0.03), with no effect of treatment observed, for all variables. An interaction 247 
effect of duration × treatment was observed for absolute V̇O2 (p=0.045) and the fractional utilisation of V̇O2max 248 
(p=0.037). Absolute V̇O2 and the fractional utilisation of V̇O2max were lower in TT120 compared to TT60 249 
(p<0.015) and TT90 (p=0.004) but no difference was observed between TT60 and TT90. Compared to PL, the 250 
absolute V̇O2 and the percentage of V̇O2max utilised was lower for NA during TT120 (p=0.01, Table 1).  251 
There was an incremental decrease in RER values with increasing trial duration such that TT60 was 252 
higher than TT90 (p=0.002) and TT120 (p=0.001), and TT90 was higher than TT120 (p=0.001). Accordingly, 253 
rates of CHO oxidation were higher in TT60 than both TT90 (p=0.006) and TT120 (p=0.001) and were higher 254 
in TT90 than TT120 (p<0.001). Consequently, rates of fat oxidation were lower in TT60 than TT90 (p=0.002) 255 
and TT120 (p<0.001). Average rates of fat oxidation were lower in TT90 than TT120 (p<0.001). The estimated 256 
amount of CHO oxidised during TT60, TT90 and TT 120 min was 301 ± 37 vs. 289 ± 38 g; 425 ± 64 vs. 413 ± 257 
54 g; and 486 ± 30 vs. 502 ± 82 g for NA and PL, respectively. No effect of treatment on the relative energy 258 
contribution from CHO and fat for TT60, TT90 or TT120 (Table 2) was observed. However, there was an 259 
incremental decline in the amount of CHO oxidised and total energy expended (Table 2), where TT120 > TT90 260 
> TT60 (p<0.001).   261 
Time, power output and rate of perceived exertion  262 
For absolute and relative power output, there were main effects of trial duration (p<0.001) and 263 
treatment (p<0.001) and time (p<0.02), with a significant interaction of treatment × duration × time for absolute 264 
power output (p=0.034) and a trend for an interaction (p=0.058) for relative power output (Table 3).  No 265 
differences in time to complete the prescribe work were measured for TT60 or TT90 trials between treatments. 266 
However, there was a significant effect of NA on time to complete TT120 (-2.4%, p<0.005, 95%CI: -2.3 – -8.2 267 
min; Figure 5). NA decreased both the absolute (p<0.001; 95%CI: -35 – -12 W) and relative power output 268 
(p<0.001; 95%CI: -8 – -3%) compared to PL in the final third of work completed (i.e. 3/3 time point).  269 
Mean absolute power output during the TTs was not different across time for NA TT60, PL TT60, PL 270 
TT90, and PL TT120.  Absolute power output in the final one-third of work was greater than for both the first or 271 
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second third of work completed for NA TT90 (p=0.016, 95%CI: 2 – 29 W; and p=0.009, 95%CI: 3 – 30 W; 272 
respectively).  Similarly, relative power output (%PPO) was greater in the final third of work than the first or 273 
second third of work completed for NA TT90 (p=0.021, 95%CI: 0.5 – 7.0% and p=0.012, 95%CI: 0.7 – 7%; 274 
respectively).  For NA TT120, absolute and relative power output in the final third of work (i.e. 3/3) were 275 
greater than the first third (i.e. 1/3) of work completed (p=0.025, 95%CI: 1 – 30 W; and p=0.042, 95%CI: 0.1 – 276 
7.0%; respectively). The final third of work in PL TT120 was significantly greater than in NA TT120 for both 277 
absolute and relative power output (p<0.001, 95%CI: 12.0 – 35.0 W, and p=0.001, 95%CI: 2.6 – 8.2%, 278 
respectively). There was no treatment or time effect on average RPE (Table 1). 279 
 280 
Discussion 281 
The first novel finding from the current study was that inhibiting lipolysis and the normal endurance 282 
exercise-induced rise in FFA availability (via NA ingestion) significantly impaired performance of a simulated 283 
cycling TT lasting 120 min. In contrast, administration of NA had no effect on TT’s of 60 or 90 min duration. A 284 
second finding was that when following sport nutrition guidelines (i.e., a high CHO diet 24 h before and pre-285 
event CHO meal), cycling TT’s lasting 60, 90 and 120 min were dependent on CHO for skeletal muscle energy 286 
metabolism, contributing between 83 and 93% of total energy (Table 2). However, for all rides there was a 287 
small, but obligatory use of fat-based fuels. 288 
The impaired TT120 performance (-2.4%, p<0.001, Figure 5) after NA administration was in contrast 289 
to one of our original hypotheses. Subjects were blinded to all treatment conditions and reported no differences 290 
in their RPE during any of the rides (Table 1). However, we cannot exclude the possibility that NA may have 291 
had a direct effect on skeletal muscle substrate turnover and oxidation. Bergstrom et al. (1969) previously 292 
reported that the arterio-venous respiratory quotient during leg exercise is higher after ingestion of NA and 293 
demonstrated that the reduced delivery of FFA to the muscles was compensated by an increased metabolism of 294 
muscle glycogen. We cannot distinguish between the different CHO-based fuels oxidised among treatments 295 
from whole-body RER measures (Table 1). However, a greater use of endogenous muscle (and liver) glycogen 296 
with NA seems plausible. Indirect support for this notion comes from the plasma glucose and lactate 297 
concentrations observed at the end of the different TTs. Plasma glucose concentrations at the final sampling 298 
point in TT120 with NA administration were lower compared to all other TTs and had declined to below resting 299 
(pre-exercise) values. Plasma lactate responses were also different with NA ingestion: at the end of TT120, 300 
plasma lactate levels failed to rise in response to an increase in power output (a sustained all-out sprint during 301 
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the final minutes of the ride) compared to values observed during other TT’s. These differential lactate levels 302 
show the importance CHO availability for supporting supramaximal sprint during the final stages of an event. 303 
Based on the training status of our subjects and the CHO-based nutritional intervention, estimated 304 
muscle glycogen stores would have been in the range of~450-550 g (Hawley and Burke 1997). As expected, the 305 
longer the TT duration, the greater the total amount of CHO oxidised. In the present study, ~300 g of CHO was 306 
utilised in TT60 suggesting that muscle glycogen availability was not rate-limiting for performance. For TTs 307 
lasting 90 min, total CHO oxidation amounted to ~400 g and endogenous muscle glycogen stores alone would 308 
have been adequate to fuel the metabolic demands of exercise. Only during TTs lasting 120 min did the total 309 
rates of CHO oxidation (~500 g) approach the upper limits of endogenous muscle glycogen stores.  It could be 310 
argued that the increased demand on glycogen and the subsequent inability to maintain blood glucose was a 311 
result of NA inhibiting the supply of glycerol from adipose tissue lipolysis for gluconeogenesis. However, the 312 
maximal rate of gluconeogenesis from glycerol during prolonged exercise in trained individuals is minimal 313 
(only 1-2 µmol glucose·min·kg-1) and  even complete inhibition of gluconeogenesis from glycerol would 314 
account for only a 2-3 g of  glucose during 120 min of cycling for a 75 kg individual (Coggan et al. 1995).  315 
A second finding of the current study was that performance of self-paced endurance cycling TT’s 316 
lasting between 60 and 120 min was highly dependent on the oxidation of CHO-based fuels, which contributed 317 
between 83 and 93% of total energy expenditure (Table 2). In a recent investigation, we reported that altering 318 
FA availability did not impair prolonged (~90 min), continuous running to fatigue (Leckey et al. 2015). In that 319 
study, blunting the exercise-induced increase in FFA via nicotinic acid ingestion did not alter patterns of 320 
substrate utilisation during a half marathon run, and carbohydrate was the primary fuel for the exercising 321 
muscles, contributing ~87% to total energy (Leckey et al. 2015). Our data showing that high rates of CHO 322 
oxidation are required to sustain high-intensity cycling (≥80% V̇O2max), regardless of plasma FFA availability, 323 
are also in agreement with the results from previous studies (Cole et al. 2014; Hawley et al. 2000; Romijn et al. 324 
1993; van Loon et al. 2001). Indeed the rates of whole-body CHO and fat oxidation measured during the current 325 
investigation are also similar to those reported by others for highly-trained endurance cyclists working at similar 326 
absolute (~300 W) and relative (>80% of V̇O2max) power outputs (Romijn et al. 1993; van Loon et al. 2001).  327 
Clearly at the intensities at which competitive endurance athletes’ train and race (>70-75% of 328 
V̇O2max), the exercising muscles are dependent on CHO for oxidative metabolism (Bergström et al. 1967) 329 
independent of training and nutritional status (Bergman and Brooks 1999) or fat availability (Romijn et al. 330 
1995). Indeed, the ability to oxidise both endogenous (Cole et al. 2014) and exogenous (Cox et al. 2010) CHO-331 
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based fuels at high rates during intense exercise appears to be a requirement for optimum endurance 332 
performance. O'Brien et al., (1993) reported that a during a simulated treadmill marathon, ‘fast runners’ 333 
(finishing time ≤2 h, 45 min) had significantly higher RER values (0.99 vs. 0.90, p≤0.05) throughout the 334 
marathon compared to a group of ‘slow runners’ (finishing time ≤3 h, 45 min). Indeed, even under conditions in 335 
which the oxidation of fat-based fuels would be expected to approach the upper limits (i.e., no pre-race CHO-336 
loading, overnight fast, and no exogenous CHO supplementation during exercise), the contribution from CHO-337 
based fuels to total energy was ~85-90% compared to ~60-70% for the fast and slow runners, respectively 338 
(O’Brien et al. 1993). 339 
Finally, despite a dependence on CHO for muscle metabolism during all TT’s, there was a small but 340 
obligatory contribution from fat-based fuels to total energy expenditure (6-17%) that increased with the duration 341 
of a TT (Table 2). Despite the administration of NA, we cannot rule out the possibility that blood-borne FFAs 342 
contributed, in part, to the rates of whole-body fat oxidation. However, based on the high absolute (~300 W) and 343 
relative (>80% of V̇O2max) exercise intensities sustained by our subjects for all TT’s, IMTG’s were likely to be 344 
the major source of lipid for oxidation by the muscle, at least during TT’s lasting 60 and 90 min (Romijn et al. 345 
1993; van Loon et al. 2001). Nevertheless, our data shows that even when lipolysis is supressed and CHO 346 
availability is high (i.e., high pre-exercise muscle and liver glycogen, high CHO availability before exercise) 347 
there is still a small requirement by the working muscle for fat-based fuels for oxidative metabolism.  348 
In conclusion, inhibiting lipolysis and the normal endurance exercise-induced rise in FFA availability 349 
had little effect on simulated TT’s lasting 60 or 90 min but impaired performance of TT’s lasting 120 min. 350 
There was a small, but obligatory contribution from fat-based fuels to total energy expenditure, which increased 351 
with the duration of a TT. However, cycling TTs lasting 60 to 120 min were highly dependent on CHO for 352 
skeletal muscle energy metabolism.  353 
  354 
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Figure Legends 428 
Figure 1. Schematic figure of experimental design. After 48 h of exercise and 24 h of dietary control, each 429 
subject undertook two series of simulated time-trials (TTs) during which they completed specific amounts of 430 
mechanical work calculated to take ~ 60, 90 and 120 min. In one series of TTs subjects were administered 15 431 
mg·kg body mass (BM)−1 of nicotinic acid (NA) before the trial and 5 mg·kg BM−1 every 30 min during the ride, 432 
while the second series acted as a placebo (PL) control. Blood samples were obtained before the start of TTs and 433 
every 1/3 of total work and respiratory expired gases sampled during warm-up, 5 min after starting, every 20 434 
min and during the last 100 kJ of work. Warm up, 15 min at 60% of Peak Power Output, 1 min rest. 435 
 436 
Figure 2. Plasma free fatty acid concentrations measured during experimental periods across each of the six 437 
time trials (n=7) for A: 60 min time trials, B: 90 min time trials, and C: 120 min time trials. Values are means 438 
±SD. NA, nicotinic acid; PL, placebo; 60, 60 min time-trial; 90, 90 min time-trial; 120,120 min time-trial. 439 
Different (p<0.05) vs † rest; ‡ one-third of exercise; b NA 60; c PL 90; d NA 90; e PL 120 and f NA 120 within 440 
time point. ͆, referring to both treatments; where symbols are both above and below the SD bars, the symbols are 441 
for the corresponding point only. 442 
 443 
Figure 3. Plasma glucose concentrations measured during experimental periods across each of the six time trials 444 
(n=7) for A: 60 min time trials, B: 90 min time trials, and C: 120 min time trials. Values are means (±SD). NA, 445 
nicotinic acid; PL, placebo; 60, 60 min time-trial; 90, 90 min time-trial; 120,120 min time-trial. Different 446 
(p<0.05) vs: †rest; ‡one-third of exercise; c PL 90; d NA 90; e PL 120 and f NA 120 within time point. ͆, referring 447 
to both treatments; where symbols are both above and below the SD bars, the symbols are for the corresponding 448 
point only. 449 
 450 
Figure 4. Plasma lactate concentrations measured during experimental periods across each of the six time trials 451 
(n=7) for A: 60 min time trials, B: 90 min time trials, and C: 120 min time trials. Values are means (±SD). NA, 452 
nicotinic acid; PL, placebo; 60, 60 min time-trial; 90, 90 min time-trial; 120,120 min time-trial. Different 453 
(p<0.05) vs: †rest; ‡one-third of exercise; c PL 90; d NA 90; e PL 120 and f NA 120 within time point. ͆, referring 454 
to both treatments; where symbols are both above and below the SD bars, the symbols are for the corresponding 455 
point only. 456 
 457 
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Figure 5. Time trials time to completion. Bars represent the means. Individual points connected by lines 458 
represent individual subjects (n=7). 459 
 19 
Tables  
Table 1. Respiratory data and rates of perceived exertion (RPE) averaged across measures taken during 
experimental periods across each of the six time trials by well-trained, male cyclists (n=7). 
  V̇O2 V̇CO2 
RER  % V̇O2max   Average RPE 
 Condition (L·min
-1) (L·min-1) 
         
PL 60 4.13 (0.42) 
§ 
3.94 (0.46) 
§ 
0.97 (0.02) 
#§ 
83 (5) 
§ 
16 (1) 
NA 60 4.10 (0.52) 3.95 (0.52) 0.98 (0.02) 82 (4) 16 (1) 
          
PL 90 4.08 (0.49) 
§ 
3.83 (0.52) 
§ 
0.96 (0.02) 
§ 
82 (5) 
§ 
16 (1) 
NA 90 4.11 (0.49) 3.88 (0.56) 0.97 (0.02) 82 (6) 16 (1) 
          
PL 120  4.04 (0.48)* 
 
  3.81 (0.52) 
 
0.94 (0.02) 
 
82 (3)* 
 
16 (1) 
NA 120 3.79 (0.46) 3.57 (0.40) 0.94 (0.02) 77 (5) 16 (1) 
Values are means (±SD). Different (p<0.05) vs. *, NA for same trial duration; #, 90 min; §, 120 min. CHO, 
carbohydrate oxidation; FAT, fat oxidation; NA, nicotinic acid; PL, placebo; RER, respiratory exchange ratio; 
V̇CO2, carbon-dioxide production; V̇O2, oxygen uptake; 60, 60 min time-trial; 90, 90 min time-trial; 120,120 
min time-trial.  
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Table 2. Fuel oxidation data based on respiratory data for rates and contributions of carbohydrate (CHO) and fat oxidised averaged across measures taken during 
experimental periods across each of the six time trials (n=7). 
  CHO  CHO   Fat  Fat  
 Energy expenditure (kJ) 
Fuel contribution (%) 
 Condition (g·min
-1) (μmol·kg-1·min-1) (g·min-1)  (μmol·kg-1·min-1) CHO Fat 
               
PL 60 4.83 (0.63) # 
§ 
360 (42) # 
§ 
0.18 (0.10) # 
§ 
8.6 (4.8) # 
§ 
5461 ± 591 # 
§ 
92 ± 4 # 
§ 
8 ± 4 # 
§ NA 60 4.99 (0.68) 360 (53) 0.14 (0.08) 6.8 (3.6) 5633 ± 602 94 ± 3 6 ± 3 
               
PL 90 4.57 (0.73) 
§ 
317 (54) 
§ 
0.24 (0.13) 
§ 
10.8 (5.4) 
§ 
8027 ± 897 
§ 
89 ± 5 
§ 
11 ± 5 
§ 
NA 90 4.72 (0.78) 343 (46) 0.22 (0.10) 10.0 (4.2) 8250 ± 1003 91 ± 4 9 ± 4 
               
PL 120 4.27 (0.75) 
 
313 (38) 
 
0.37 (0.16) 
 
16.4 (6.4) 
 
10543 ± 1170  83 ± 7  17 ± 7  
NA 120 3.96 (0.35) 293 (41) 0.36 (0.14) 15.1 (1.9) 10287 ± 896  83 ± 4  17 ± 4  
Values are means (±SD). Different (p<0.05) vs. *, NA for same trial duration; #, 90 min; §, 120 min. CHO, carbohydrate oxidation; FAT, fat oxidation; NA. 
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Table 3. Absolute and relative power output across the duration of each time trial during experimental periods 
across as performed (n=7). 
 Power (W) Power (%PPO) 
Condition 1/3 2/3 3/3 1/3 2/3 3/3 
PL 60 309 ± 46 303 ± 44 311 ± 33 76 ± 5 75 ± 4 77 ± 4 
NA 60 305 ± 48 297 ± 52 307 ± 46 75 ± 4 73 ± 5 76 ± 4 
PL 90 302 ± 38 296 ± 41 304 ± 49 75 ± 5 73 ± 5 75 ± 6 
NA 90 294 ± 46 293 ± 46 309 ± 49‡₤ 72 ± 7 72 ± 6 76 ± 4‡₤ 
PL 120 304 ± 39 300 ± 41 304 ± 50* 75 ± 3 73 ± 3 74 ± 5* 
NA 120 296 ± 43 292 ± 44 281 ± 37‡ 72 ± 2 71 ± 3 69 ± 7‡ 
Values are means (± SD). Different (p<0.05) vs. *, NA for same trial duration and time point; ‡, one-third of 
exercise within trial duration; ₤, two-thirds of exercise within trial duration. 60, 60 min time-trial; 90, 90 min 
time-trial; 120,120 min time-trial; W, watts; %PPO, % peak power output. 
 
